Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

KRAS Interaction Inhibitor (HM101207)," which is being developed as a next-generation targeted anticancer innovative ...

Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for approximately 90% of all liver cancer cases. Given that the development ...

Mitochondrial dysfunctions are associated with a variety of pathologies, and the onset and progression of disease are accompanied by alterations in extracellular biochemical and mechanical signals.

LC3-associated phagocytosis (LAP) is a specialized process for degrading dead cells, microbes or other particles. It plays a ...

LC3-associated phagocytosis (LAP) is a specialized process for degrading dead cells, microbes or other particles. It plays a ...

Want to know which companies are leading innovation in Liver Cancer? Dive into the full pipeline insights @ Liver Cancer Clinical Trials Assessment The Liver Cancer Pipeline Report provides disease ...

In the field of cancer research, understanding the cellular machinery involved in malignancy and drug resistance is crucial for developing effective ...

LC3-associated phagocytosis (LAP) is a specialized process for degrading dead cells, microbes or other particles.

In tissue biopsies, cancer cells are frequently observed to have nuclei (the cell's genetic information storage) that are ...